The Latest Breaking News from CMS

The Biden administration is urging states to slow down their efforts to remove people from Medicaid

Leqembi could become the first treatment of its kind to receive traditional approval from the FDA.

Software as a Service (SaaS) has been a popular business model in the IT sector for years and is now rapidly expanding in the digital signage world, delivering unmatched benefits for end users and AV integrators alike. However, true digital signage SaaS solutions are few and far between.

Though supplemental benefits often draw seniors to Medicare Advantage plans, insurance experts question their value.

Millions of patients and their caregivers breathed a collective sigh of relief when drugmaker Eli Lilly recently announced its new experimental Alzheimer’s medication appears to slow cognitive decline by 35%. The Food and Drug Administration could approve the new treatment, donanemab, as soon as this year.

Georgia is the latest state to enact a law that allows hospitals to create independent police forces. Critics worry the law enforcement focus could have unintended consequences.

Whether Medicare will or won’t cover certain health care costs may now depend on whether you are in Traditional Medicare or a private insurer’s Medicare Advantage plan.

Medicare drug price negotiations: Early signs have emerged of how these key talks will be handled.

While there is no known cure for Alzheimer’s disease, there are promising — but expensive — treatments.